An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
Article
[키워드] 95% CI
acquisition
activated
acute phase
Analysis
analyzed
anti-SARS-CoV-2 antibody
AUC
Cell mediated immunity
Comorbidities
Course
COVID-19
COVID-19 patient
Critical
Diagnosis
disease
Diseases
evaluate
event
Evolution
Factor
flow cytometry
form
four group
healthy controls
Hospitalization
identify
imbalanced immune response
immune response
Immunity
immunological
independent
Infection
inflammatory parameters
less
pathology
Patient
predominant
progression
protective factor
Randomized
response
robust
SARS-CoV-2 infected individual
SARS-CoV2
severe COVID-19 patient
severity
specificity
subset
Symptomatic patients
T helper
T-cell
T-cell subsets
T-cells
Th1
Th1 immunity
Th1 response
Th17
Th2
the disease
the SARS-CoV-2
[DOI] 10.3390/biomedicines10020296 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/biomedicines10020296 PMC 바로가기 [Article Type] Article